Insight journal - Company

Stada: From co-operative pharmacy to generics/OTC giant

Posted on 17 January 2014

Tags: , , ,

STADA is a major global pharmaceutical company offering generics and OTC products. Focusing on stomach medicines, anti-hypertensive agents and anti-inflammatory agents, the company has gradually grown to become one of the largest generics providers in the world.

STADA is behind the well know products Omeprazole and Diclofenac. It’s branded well know products include cold product Grippostad, Parkinson’s disease medication ApoGo and Suncream Ladival.

STADA attributes its ‘Cheap to market’ strategy to a lot of its success. The company has established itself and its excellent sales and marketing strategy in so many countries through its distributor partnerships that it can successfully take products to market. This in turn provides significant revenues for the company due to successful product launches. The company also only markets products that already include patented API's rather than researching its own.

The word STADA originates from Standardarzneimittel Deutscher Apotheker which translates into Standard Drugs of German Pharmacists. From its humble beginnings in Dresden, Germany in 1985, when STADA started business trading as a co-operative pharmacy, the company has since moved locations and aggressively grown fairly rapidly acquiring new companies and expanding into international markets. From the 1970’s the company really started to take shape after it became public and officially entered the generic market. Generics seem to be a good fit and helped to boost the company’ sales which in turn helped to fund the purchase of several new companies around the world; in 1986 STADA expanded internationally in Switzerland and Austria, this was closely followed by the acquisitions of French CentraFarm B.V and Belgium based N.V. Eurogenerics. Since then the company has set up several distribution partnerships and firmly established itself just in the USA with the creation of STADA Pharmaceuticals.

Partnering to grow

STADA doesn't reveal too much in what it looks for in a partner but it is clear to see that there are two routes of partnering employed by STADA; in-licensing and distribution. Naturally the company regularly looks to in-license products; prescription and generic. The company can offer a product global exposure and guaranteed sales, so it is seen as very attractive partner to many smaller companies with innovative products. The company actually has an email address set up that is solely dedicated to in licensing, so it illustrates its dedicated desire to seek out the best products. The second partnering route is distribution; the company has set up many partnerships with companies who have a local presence in their region. For example in Russia, the company has partnerships with around 10 or so companies.

Partnering outreach

STADA is often present at a large number of partnering events throughout the year. Partnering events are a great place to meet lots of potential partners face to face in a short space of time.

Events with STADA presence include but are not limited to:

  • BIO International Convention and Business Forum
  • BioEurope / BioEurope Spring

For a full list of forthcoming partnering events where you could meet with STADA in person visit Current Partnering’s Event calendar.  

Contacting Stada for partnering

Stada can be contacted in relation to partnering through a number of channels. Here is a list of the most common channels: 

Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face contact but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.

See Current Partnering’s event calendar for details of forthcoming events. 

Direct contact: there are several sources of direct contact with Stada business development team

Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.

Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. 

LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel.

Many of Stada's business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit Stada's Linkedin Page  

Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. This is the form available (link no longer available) on the Stada Pharmaceutical website for potential partnering opportunities.  

Raveena Bhambra

* www.STADA.com

More

Summary profile data for STADA

Partnering activity for STADA

M&A activity for STADA

 

Available reports from Current Partnering

Report: Partnering Agreements with STADA 2005-2013

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for STADA

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on STADA company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply